Bioxcel Therap
BTAI0.86720.77% ( +0.0066 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Bioxcel Therap(BTAI) predict that the Revenue is 206 K (+22.62%), Miss estimate;the EBIT is -10.22 M (-1.23%), Miss estimate;the EPS is -0.54 (+64%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B22.62%
0.00B127.08%
-0.00B104.46%
EBITMiss expectations
-0.01B1.23%
-0.01B2.29%
-0.00B3.52%
EPSMiss expectations
-0.5464.00%
-0.476768.22%
-0.06334.22%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf